| ATS 2024 CONFRENCE PROGRAM | 1 |
| FRONT COVER | 1 |
| WELCOME MESSAGE | 3 |
| FRIDAY, MAY 17 | 5 |
| PG1A CRITICAL CARE ULTRASOUND ANDECHOCARDIOGRAPHY I | 5 |
| PG2 BRONCH DAY 2024: ACOMPREHENSIVE, HANDS-ON GUIDETO BASIC BRONCHOSCOPY, EBUS,AND GUIDED BRONCHOSCOPY | 5 |
| PG3 HOME MECHANICAL VENTILATION:EVIDENCE AND HANDS ONEXPERIENCE WITH THE EXPERTS | 6 |
| LET ME CATCH MY BREATH: BESTPRACTICES IN PULMONARYFUNCTION TESTING | 8 |
| PG6 COPD 2024: STATE OF THE ART | 9 |
| PG7 A PRIMER ON HEALTH EQUITYRESEARCH FOR CLINICAL,TRANSLATIONAL, AND BASICSCIENTISTS | 9 |
| SATURDAY, MAY 18 | 11 |
| PG1B CRITICAL CARE ULTRASOUND ANDECHOCARDIOGRAPHY II | 11 |
| PG8 BRONCHIECTASIS AND NTMPULMONARY DISEASE: RISKFACTORS, MANAGEMENT, ANDRECENT ADVANCES | 11 |
| PG9 STATE OF THE ART: LUNG CANCERIN 2024 | 12 |
| PG10 WOMEN IN MEDICINE: EMPOWERINGAND DEVELOPING THE NEXTGENERATION OF WOMEN LEADERSIN MEDICINE | 13 |
| PG11 STATE OF THE ART INCARDIOPULMONARY EXERCISETESTING: PRINCIPLES AND BESTPRACTICES | 14 |
| PG12 NAVIGATING LONGITUDINAL CARETRANSITIONS FOR INFANTS,CHILDREN, AND ADULTS WITHBRONCHOPULMONARY DYSPLASIA | 15 |
| PG13 TYPE 2 ASTHMA AND BEYOND:MOLECULAR MECHANISMS,PHYSIOLOGY, AND TREATMENT | 16 |
| PG14 INTERSTITIAL LUNG DISEASE:IMPLEMENTING GUIDELINES FORPATIENT CENTERED CARE | 16 |
| PG15 YOU’RE THE SWAN THAT I WANT!: APRIMER ON RIGHT HEARTCATHETERIZATION | 17 |
| PG16 FUNCTIONAL ASSESSMENT OF THELUNG: A STATE OF THE ART REVIEWOF OLD AND EMERGING TOOLS | 18 |
| PG17 COMPREHENSIVE APPROACH TOMANAGEMENT OF COMMONPLEURAL DISEASES | 18 |
| PG18 PATHOPHYSIOLOGICALMECHANISMS IN COPD FROM THEMULTI-OMICS PERSPECTIVE | 19 |
| NETWORKING SUPER CENTER | 20 |
| OPENING CEREMONY | 20 |
| THE NETWORKING EXCHANGE FOR EARLY CAREER PROFESSIONALS | 21 |
| THE NETWORKING EXCHANGE FOR EARLY CAREER PROFESSIONALS | 21 |
| SUNDAY, MAY 19 | 22 |
| SUNDAY MORNING | 22 |
| MEET THE EXPERT SEMINARS | 22 |
| K1: KEYNOTE SERIES | 22 |
| A1 CLINICAL YEAR IN REVIEW 1 | 22 |
| A2 AJRCCM, JAMA, NEJM DISCUSSIONSON THE EDGE: REPORTS OFRECENTLY PUBLISHED PULMONARYRESEARCH | 23 |
| A3 FELLOWS CASE CONFERENCE | 23 |
| A4 ICU EARLY MOBILIZATION: SHOULDWE KEEP MOVING OR MOVE ON? | 24 |
| A5 MULTI-OMIC AND SINGLE CELLAPPROACHES FOR ELUCIDATINGCELLULAR BIOLOGY ANDPATHOBIOLOGY OF LUNG DISEASE | 24 |
| A6 ROLE OF SEX IN PULMONARYDISEASE ACROSS THE LIFESPAN | 25 |
| A7 WE’RE REALLY COOKING NOW!PRO-CON DEBATE ON GAS STOVERISKS TO LUNG HEALTH | 25 |
| A8 CHANGES IN COGNITION AND MOOD;A NEW FRONTIER FOR PULMONARYREHABILITATION | 26 |
| A9 TRANSFORMING HEALTHCARE:CHATGPT AND LANGUAGE MODELSIN CLINICAL PRACTICE ANDSCIENTIFIC RESEARCH | 26 |
| A10 UNLOCKING THE THERAPEUTICPOTENTIAL OF TRAINED IMMUNITY INRESPIRATORY DISEASES | 27 |
| A11 LEVERAGING MULTI-OMICS TOADVANCE PRECISION MEDICINE INBRONCHOPULMONARY DYSPLASIA | 28 |
| A12 FORGOTTEN POPULATIONS:DETERMINING RESEARCHPRIORITIES IN HISTORICALLYUNDERSTUDIED VULNERABLECOMMUNITIES | 28 |
| A13 TOWARDS IMPLEMENTATION: NEWBIOMARKERS IN ILD | 29 |
| A15 PEDIATRIC ASTHMA - CLINICAL ANDTRANSLATIONAL RESEARCH | 30 |
| A16 NTM WITH A SIDE OF BRONCHIECTASIS | 30 |
| A17 COPD CHRONICLES: DECODING THEPATHOGENESIS OF A COMPLEXDISEASE | 31 |
| A18 FIXING WHAT’S BROKEN: NOVELTHERAPEUTICS FOR LUNGREMODELING | 31 |
| A19 THE FRONTLINE SLEEP APNEA:INNOVATIONS IN OSA | 32 |
| A21 HEALTH SERVICES RESEARCH:HIGHLIGHTS OF EPIDEMIOLOGY,POPULATION HEALTH, COST, ANDOUTCOMES | 32 |
| A22 CRITICAL CARE MEDICINE:ADVANCING BEHAVIORAL SCIENCESAND HEALTH SERVICES RESEARCH | 33 |
| A23 INVESTIGATING HETEROGENEITY INSEPSIS AND PNEUMONIA: TRIALS,COHORTS, AND PATIENT-ORIENTEDRESEARCH | 34 |
| A24 EVERY BREATH YOU TAKE:RESPIRATORY FAILURE CASEREPORTS | 35 |
| A25 WORDS MATTER: COMMUNICATIONAND PARTNERSHIP IN THE ICU | 36 |
| A26 IMPROVING OUTCOMES INSARCOIDOSIS, RARE LUNG DISEASEAND LUNG TRANSPLANT | 36 |
| A27 EMERGING TREATMENTS ANDTHERAPEUTIC STRATEGIES IN COPD:RESULTS OF CLINICAL TRIALS ANDOBSERVATIONAL STUDIES | 37 |
| A28 INTERVENTIONAL PULMONOLOGY INTHE PEDIATRIC AGE | 39 |
| A29 WHAT IS YOUR DAMAGE?IMAGING-BASED PHENOTYPESOF COPD | 39 |
| A30 CHALLENGES AS OPPORTUNITIES TOIMPROVE LUNG CANCER DIAGNOSISAND CARE | 40 |
| A31 IMMUNE CELL MOLECULARACTIVATION SWITCH IN LUNG INJURYAND INFLAMMATION | 41 |
| A32 BENCH TO BEDSIDE IN ILD | 42 |
| A33 PUSHING THE IMMUNE SYSTEM TOTHE LIMIT: CASE STUDIES | 43 |
| A34 LATE BREAKING ABSTRACTS INASTHMA AND ALLERGICINFLAMMATION | 44 |
| A35 ASTHMA AND COPD: EPIDEMIOLOGY,TREATMENT, OUTCOMES, ANDSOCIAL DETERMINANTS | 45 |
| A36 PROGRESS IN LUNG CANCER ANDLUNG CANCER SCREENING | 46 |
| A37 SLEEP MEDICINE IN THE 21STCENTURY | 47 |
| A38 HIGHLIGHTS OF BEHAVIORALSCIENCE AND HEALTH SERVICESRESEARCH | 48 |
| A39 EDUCATING THE EDUCATORS:ADVANCES IN CRITICAL CAREMEDICAL EDUCATION | 49 |
| A40 IMPLEMENTING BEST PRACTICES INTHE ICU | 50 |
| A41 REVIEWING ALL THE SYSTEMS:ADVANCES IN NON-PULMONARYCRITICAL CARE | 51 |
| A42 TREATING THE WHOLE PERSON INAND AFTER THE ICU: HOLISTIC ICUCARE, TEAM COMMUNICATION, ANDLONG-TERM OUTCOMES | 52 |
| A43 SHOCK AND AWE: NOVEL SHOCKCASES IN THE ICU | 53 |
| A44 4/4 BOTTLES OF WHAT?!ENDOCARDITIS AND BACTEREMIACASE REPORTS | 54 |
| A45 VARIETY IS THE SPICE OF LIFE:CRITICAL CARE CASE REPORTPOTPOURRI | 56 |
| A47 ILD OUTCOMES | 59 |
| A48 COPD EXACERBATIONS ANDHOSPITALIZATIONS: DETERMINANTSAND DRIVERS | 61 |
| A49 RESEARCH STUDIES AND CASEREPORTS IN INTERVENTIONALPULMONARY AND PLEURAL DISEASE | 62 |
| A50 ALL ABOUT EFFUSIONS: BILE,CHYLE, URINE, PANCREATIC FLUID,AND OTHER RARE CASE REPORTS | 64 |
| A51 CASE REPORTS INAUTOIMMUNE-RELATED LUNGDISEASE | 65 |
| A52 CASE REPORTS IN DRUG-INDUCEDLUNG DISEASE | 67 |
| A53 CASE REPORTS IN ILD | 68 |
| A54 EXPLORING ASTHMA AND COPD:DIVERSE INSIGHTS FROM GLOBALPERSPECTIVES | 69 |
| A55 MEDICAL MAYHEM: CASE REPORTSOF LUNG INJURY IN VAPING,MARIJUANA, AND COCAINE USE | 70 |
| A56 BUZZING THE TOWER: NOVELDIAGNOSTIC AND MONITORINGTOOLS IN PH | 71 |
| A57 SOCAL GROUPIES IN PH: GROUP 2PH AND LEFT HEART DISEASE | 72 |
| A58 EXPANDING OUR RE(PERT)OIRES INSAN DIEGO: NOVEL CLINICALDISCOVERIES IN PULMONARYEMBOLISM | 72 |
| A59 WAITING FOR SUNSET AT LA JOLLA:LATE BREAKING ABSTRACTS | 74 |
| A60 REACHING FOR NEW (SHERMAN)HEIGHTS: INTERESTING CASES INPULMONARY THROMBOEMBOLICDISEASE | 74 |
| A61 PEDIATRIC INFECTIONS | 75 |
| A62 PULMONARY INVOLVEMENT INPEDIATRIC SYSTEMIC DISEASE | 76 |
| A63 CHILDHOOD INTERSTITIAL ANDDIFFUSE LUNG DISEASEs | 77 |
| A64 TACKLING TUBERCULOSIS: INSIGHTSAND INNOVATIONS | 78 |
| A65 FUNGI CHRONICLES | 80 |
| A66 BACTERIA CASES UNLEASHED | 81 |
| A67 COUGH, VENTILATORYCONSTRAINTS, AND NEURALVENTILATORY CONTROL:IMPLICATIONS TO PULMONARYREHABILITATION | 82 |
| A68 UNVEILING NOVEL AVENUES IN IPFTHERAPIES | 83 |
| A69 PATHOGENESIS OF INTERSTITIALAND PLEURAL DISEASES | 84 |
| A70 MOLECULAR INSIGHTS INTO ILDPATHOGENESIS | 85 |
| A71 CUTTING EDGE TECHNOLOGIES FORLUNG DISCOVERY | 86 |
| A72 EPITHELIAL CELLS: KEY CULPRITS INPULMONARY FIBROSIS | 87 |
| A73 GENOMICS AND EPIGENOMICS INLUNG DISEASES | 88 |
| A74 MITOCHONDRIA AND METABOLISM INLUNG HEALTH AND DISEASE | 88 |
| A75 REVISITING CURRENT METHODS INPULMONARY FUNCTION TESTING | 89 |
| A76 ASSESSING RISKS AND OUTCOMESIN INTERSTITIAL LUNG DISEASE | 90 |
| A77 DECODING THE MOLECULAR MAZEOF SLEEP APNEA | 91 |
| A78 THE SPACE BETWEEN: PLEURALCASES | 91 |
| A79 DEFINING LUNG CANCERDEVELOPMENT ANDCHARACTERISTICS | 92 |
| ME101 RESCUING THE STRUGGLINGLEARNER: BEST PRACTICES FORREMEDIATION | 93 |
| DIVERSITY FORUM | 93 |
| SUNDAY MID-DAY | 93 |
| CC1 ADULT PULMONARY CLINICAL CORECURRICULUM | 93 |
| SPS1 SPOTTING BRONCHIECTASISTREATMENT NEEDS: FOCUS ONDIAGNOSIS AND EXACERBATIONS | 94 |
| SPS2 CONTRASTING CONCURRENTGUIDELINES AND MAKINGSENSE OF THEIR DIFFERENCES- ATS AND ESICM ARDSGUIDELINES | 94 |
| MD1 RED IN ACTION I: LUNG RESEARCHHIGHLIGHTS FROM AJRCMB | 94 |
| MD2 STUDY UPDATES FROM THEAMERICAN LUNG ASSOCIATION’SAIRWAY CLINICAL RESEARCHCENTERS NETWORK | 95 |
| MD3 COPDGENE: UPDATES IN COPDEPIDEMIOLOGY, IMAGING, ANDBIOMARKERS | 95 |
| MD4 PRECISION ENVIRONMENTAL HEALTHAND ALL OF US: AN OPPORTUNITY FORPULMONARY MEDICINE | 96 |
| MD5 PRECISIONS - APPLYING PRECISIONMEDICINE APPROACHES TOPULMONARY FIBROSIS | 96 |
| MD6 CURRENT STATE OFPATIENT-VENTILATORINTERACTIONS: NOMENCLATURE,RESEARCH, AND OUTCOME | 97 |
| MD7 THE MOLECULAR ATLAS OF LUNGDEVELOPMENT (LUNGMAP), PHASE 2 | 97 |
| MD8 PULMONARY UPDATE FROM THE USFOOD AND DRUG ADMINISTRATION | 98 |
| MD9 AIRWAY DISEASE ENDOTYPINGUSING OMICS | 98 |
| MD10 NIOSH OCCUPATIONAL RESPIRATORYDISEASE HEALTH HAZARDEVALUATIONS AND FIELD STUDIES | 98 |
| MD11 SYSTEMS BIOLOGY IN INFECTIOUSDISEASES | 99 |
| MD12 THE NHLBI LUNG TRANSPLANTCONSORTIUM | 99 |
| MD13 TWO DECADES OF PROGRESSFROM THE GENETIC DISORDERSOF MUCOCILIARY CLEARANCECONSORTIUM | 100 |
| PCC1 PEDIATRIC CLINICAL CORECURRICULUM 1 | 100 |
| SUNDAY AFTERNOON | 101 |
| SPS3 ATS/NHLBI INCLUSIVE PRACTICESIN CLINICAL TRIAL RECRUITMENT(PART 1) | 101 |
| CC2 ADULT SLEEP CLINICAL CORECURRICULUM | 101 |
| A81 PEDIATRIC YEAR IN REVIEW | 102 |
| A82 NEJM, JAMA, AJRCCM DISCUSSIONSON THE EDGE: REPORTS OFRECENTLY PUBLISHED CRITICALCARE RESEARCH | 102 |
| A83 GREAT CASES: CLINICAL, RADIOLOGIC,AND PATHOLOGIC CORRELATIONS BYMASTER CLINICIANS | 102 |
| A84 COMBINED PULMONARY FIBROSISAND EMPHYSEMA: FROMPATHOGENESIS TO DIAGNOSIS ANDTHERAPEUTIC IMPLICATIONS | 103 |
| A85 FROM MECHANISM TO PREDICTION:APPLICATION OF METABOLOMICSACROSS THE PULMONARY/CRITICALCARE SPECTRUM | 104 |
| A86 BEYOND THE BUNDLE: SEPSIS CAREBEFORE ARRIVAL AND AFTERSURVIVAL | 104 |
| A87 IS IT IN THE AIR? EMERGING RISKSFOR LUNG CANCER | 105 |
| A88 POST-TB LUNG DISEASE: FROMGLOBAL BURDEN TO MOLECULARMECHANISMS | 105 |
| A89 MECHANICAL FORCES IN LUNGDISEASE | 106 |
| A90 METABOLITE INTERACTIONS INHEALTH AND DISEASE: UNVEILINGTHE MUTUAL FEEDING BETWEENHOST AND MICROBIOTA | 106 |
| A91 WHAT ARE THE GREATEST GLOBALCHALLENGES TO LUNG HEALTH? | 107 |
| A93 CRITICAL CARE AND ACUTE CAREMEDICINE: DISPARITIES, QUALITYIMPROVEMENT, AND OUTCOMES | 107 |
| A94 OPTIMIZING ICU PRACTICE, TEAMS,AND INFRASTRUCTURE | 108 |
| A95 CLIMATE CHANGE AND HEALTHDISPARITIES IN LUNG DISEASE | 108 |
| A96 IMPROVING THE CARE OF PATIENTSWITH DIVERSE PULMONARYCONDITIONS AND SLEEPDISORDERED BREATHING | 109 |
| A97 IT’S (NOT) A SMALL WORLD:MOLECULAR AND PHYSIOLOGICEPIDEMIOLOGY IN PAH | 109 |
| A98 BEST INTERVENTION ABSTRACTS INPULMONARY REHABILITATION | 110 |
| A99 LOOKING UNDER THE HOOD:DIAGNOSTIC TOOLS TO PHENOTYPESEVERE ASTHMA | 110 |
| A101 FULL METAL JACKET TARGETINGCOPD AND CHRONIC AIRWAYSDISEASE | 111 |
| A102 EVALUATING THE INTERSECTIONBETWEEN AUTOIMMUNITY,IMMUNODEFICIENCY, ANDINTERSTITIAL LUNG DISEASES | 112 |
| A103 DYSREGULATED PATHWAYS INSEPSIS AND LUNG INJURY:SEARCHING FOR TREATABLETRAITS | 113 |
| A104 ADVANCES IN THE DIAGNOSIS ANDTREATMENT OF ILD | 114 |
| A105 RAPID: SICK ON THE JOB -OCCUPATIONAL LUNG DISEASE | 115 |
| A106 PEDIATRIC SLEEP, VENTILATION,AND CRITICAL CARE RESEARCH | 115 |
| A107 INFECTIONS IN THEIMMUNOSUPPRESSED ANDIMMUNOCOMPROMISED HOST | 116 |
| A108 COPD PATHOGENESIS: OPENINGTHE PANDORA BOX | 117 |
| A109 I JUST CAN’T GET ENOUGH:DEFECTS IN VENTILATION AND GASEXCHANGE | 118 |
| A110 NEW FRONTIERS IN SLEEP APNEADIAGNOSIS AND THERAPIES | 119 |
| MONDAY, MAY 20 | 120 |
| MONDAY MORNING | 120 |
| MEET THE EXPERT SEMINARS | 120 |
| K2: KEYNOTE SERIES | 120 |
| B1 CLINICAL YEAR IN REVIEW 1 | 121 |
| B2 BRING YOUR BEST BIOMARKER:MOLECULAR SUCCESS STORIES INCHRONIC LUNG DISEASE | 121 |
| B3 SPECIAL CONSIDERATIONS FORPATIENTS WHO ARE TRANSGENDEROR NonBINARY IN PULMONARYMEDICINE | 122 |
| B4 EXTRACORPOREAL MEMBRANEOXYGENATION (ECMO) FOR SEVEREACUTE RESPIRATORY DISTRESSSYNDROME IN A POST-PANDEMICWORLD | 122 |
| B5 ROBERT SENIOR MEMORIALSYMPOSIUM - COPD AS ANENDOTHELIAL DISORDER:ENDOTHELIAL INJURY LINKINGLESIONS IN THE LUNGS AND OTHERORGANS | 123 |
| B6 INTEGRATING EVIDENCE FROMRANDOMIZED TRIALS ANDOBSERVATIONAL COHORTS INSLEEP DISORDERED BREATHING | 123 |
| B7 PATHOGENIC CONCEPTS IN PAHREVISITED? A MULTIGENERATIONALPERSPECTIVE | 124 |
| B8 SEVERE CHILDHOOD ASTHMA: NEWPERSPECTIVES ON PHENOTYPES,MANAGEMENT, AND DISEASEREMISSION | 125 |
| B9 50 YEARS OF DYSANAPSIS: WHATWE HAVE LEARNED AND WHERE WEARE GOING | 125 |
| B11 PRESIDENT'S SYMPOSIUM PASSION,PERSEVERANCE, AND QUANTUM LEAPS:CELEBRATING ADVANCES IN LUNGCANCER | 126 |
| B12 QUITTING IS WINNING: TOBACCOAND E-CIGARETTE CESSATION | 127 |
| B13 BREAKING NEWS: CLINICAL TRIALRESULTS IN PULMONARY MEDICINE | 127 |
| B14 LATE BREAKING ABSTRACTS:SCIENCE THAT WILL IMPACTCLINICAL CARE | 128 |
| B15 THE MACROPHAGE IN ALL ITSGLORY | 128 |
| B16 NOVEL INSIGHTS INTO ASTHMAPATHOGENESIS | 129 |
| B17 CUTTING EDGE RESEARCH ONDISPARITIES IN PULMONARY ANDCRITICAL CARE MEDICINE | 129 |
| B18 BRIDGING GAPS TO IMPROVELONG-TERM OUTCOMES | 130 |
| B19 ‘OMICS TO ENDOTYPEEXPOSURE-RELATED LUNG DISEASE | 130 |
| B20 LUNG SCREENING: ONE SIZE DOESNOT FIT ALL | 131 |
| B21 RESEARCH STUDIES ININTERVENTIONAL PULMONARY ANDPLEURAL DISEASE | 131 |
| B22 NEW FRONTIERS IN ENVIRONMENTALAND OCCUPATIONAL LUNG DISEASERESEARCH | 132 |
| B23 PROMOTING HIGH-QUALITY PATIENTANDFAMILY-CENTERED CRITICALCARE DURING THE ICU STAY ANDBEYOND | 133 |
| B24 WHALE WATCHING: A “RAPID” TOUROF PAH PATHOGENESIS | 134 |
| B25 LUNG INVOLVEMENT IN SICKLE CELLDISEASE AND AFTER HEMOPOIETICSTEM CELL TRANSPLANT | 134 |
| B26 UNLOCKING NTM/BRONCHIECTASISMYSTERIES | 135 |
| B27 PULMONARY REHABILITATION:ONLINE RESOURCES, COMPLEXPATIENTS AND PALLIATIVE CARE | 136 |
| B28 LUNGS THORUGH TIME: EXPLORINGLUNG AGING | 137 |
| B29 BIOMARKERS AND NEWTHERAPEUTICS TARGETS IN LUNGFIBROSIS | 138 |
| B30 SCARRED FOR LIFE:TRANSLATIONAL RESEARCH ININTERSTITIAL ABNORMALITIES ANDLUNG FIBROSIS | 139 |
| B31 AIRWAY EPITHELIAL INFLAMMATIONAND DYSFUNCTION | 140 |
| B32 BIOMARKERS AND TRANSLATIONALSTUDIES IN COPD AND CHRONICAIRWAYS DISEASES | 141 |
| B33 COVID-19, LUNG INJURY, AND SEPSIS | 142 |
| B34 PROVIDER-CENTERED HEALTHSERVICES RESEARCH | 142 |
| B35 CRITICAL CARE QUALITYIMPROVEMENT, TRAINING, ANDHEALTH SERVICES RESEARCH | 143 |
| B36 INTERSTITIAL LUNG DISEASE,CYSTIC FIBROSIS, ANDSARCOIDOSIS: CLINICALPERSPECTIVES | 144 |
| B37 CRITICAL LAB VALUE ALERT!HORMONES AND ELECTROLYTES INTHE ICU | 144 |
| B38 OPTIMIZING MECHANICALVENTILATION AND VENTILATORLIBERATION | 146 |
| B39 MODELING MECHANICALVENTILATION AND OXYGENSUPPORT | 147 |
| B40 COVID-19 EPIDEMIOLOGY IN 2024 | 148 |
| B41 INNOVATION INCUBATOR: NOVELSEPSIS MECHANISMS AND MARKERS | 149 |
| B42 ALPHABET SOUP: APLS, HLH, HUS,TTP, SCD, AND DIC IN THE ICU | 150 |
| B43 “WE PROBABLY NEED AN IDCONSULT” - ATYPICAL INFECTIONSIN THE ICU | 151 |
| B44 MITIGATING HARM: MANAGINGEXPECTED AND UNEXPECTEDCOMPLICATIONS IN THE ICU | 152 |
| B45 AIR THAT SHOULDN’T BE THERE:PNEUMOTHORACES, AIR LEAKS ANDMUCH MORE | 154 |
| B46 UP AND COMING: ILD BIOMARKERS | 155 |
| B47 LUNG TRANSPLANT | 156 |
| B48 NEW TREATMENTS IN DIFFUSEPARENCHYMAL LUNG DISEASE | 157 |
| B49 RESEARCH STUDIES IN DYSPNEAAND COUGH | 158 |
| B50 EMERGING RESEARCH INALPHA-1-ANTITRYPSIN DEFICIENCY | 159 |
| B51 LEVERAGING ADMINISTRATIVE ANDLARGE DATASETS TO UNDERSTANDCOPD EPIDEMIOLOGY | 159 |
| B52 EVIDENCE FOR THERAPEUTICSTRATEGIES IN COPD: FROMESTABLISHED TO EMERGING | 160 |
| B53 CASE REPORTS IN CYSTIC LUNGDISEASE | 161 |
| B54 CASE REPORTS IN ONCOLOGICTREATMENT-RELATED LUNGDISEASE | 162 |
| B55 EXPLORING LUNG HEALTH ACROSSPOPULATIONS | 162 |
| B56 VGDF: HAZARDS, EXPOSUREASSESSMENT, AND HEALTH EFFECTSFROM WILDFIRES, BURN PITS, AIRPOLLUTION | 163 |
| B57 MECHANISTIC INSIGHTS INENVIRONMENTAL ANDOCCUPATIONAL DISEASES | 165 |
| B58 WE ARE ON A MISSION (BEACH):HOT CASES IN PULMONARYHYPERTENSION | 166 |
| B59 DEFINING DISPARITIES INPULMONARY VASCULAR DISEASES | 167 |
| B60 CYANOTIC PACIFIC BLUE: GROUP 3PH AND HYPOXIC LUNG DISEASE | 168 |
| B61 THE NEED FOR SPEED: ARTIFICIALINTELLIGENCE IN PVD | 169 |
| B62 A LEGO STORY: MOLECULARBUILDING BLOCKS IN PULMONARYHYPERTENSION | 169 |
| B63 BRONCHOPULMONARY DYSPLASIAAND DEVELOPMENTAL LUNGDISEASE | 170 |
| B64 PEDIATRIC SLEEP ANDNON-INVASIVE VENTILATION | 171 |
| B65 CYSTIC FIBROSIS AND PRIMARYCILIARY DYSKINESIA | 172 |
| B66 DYNAMIC CASES OF INFECTIOUSDISEASES | 173 |
| B67 VIRAL RESPIRATORY INFECTIONSINSIGHTS | 174 |
| B68 TUBERCULOSIS TALES: CASESUNVEILED | 176 |
| B69 PULMONARY REHABILITATION:COVID-19, CRITICAL ILLNESS, ANDQUALITY IMPROVEMENT | 177 |
| B70 COPD IN THE SPOTLIGHT: INSIGHTSINTO DISEASE PATHOGENESIS | 178 |
| B71 ASTHMA PATHOGENESIS: MORETHAN MEETS THE EYE | 179 |
| B72 LUNG INFECTIONS AND COVID-19:INSIGHTS, INNOVATIONS, ANDIMPACT | 180 |
| B73 NAVIGATING THE STORM:UNDERSTANDING ACUTE LUNGINJURY | 181 |
| B74 BREATHING NEW LIFE: LUNGTRANSPLANT PATHOGENESIS ANDMECHANISMS | 182 |
| B75 POLLUTION AND LUNG HEALTH:MECHANISMS AND PATHOGENESIS | 183 |
| B76 CHRONIC AIRWAY DISEASES: ABOVEAND BEYOND | 183 |
| B77 NEW APPROACHES IN LUNGVENTILATION | 184 |
| B78 A DEEPER DIVE INTO EXERCISE | 184 |
| B79 AIRWAY SMOOTH MUSCLE INASTHMA | 185 |
| B80-1 METHODOLOGICALADVANCEMENTS IN PULMONARYIMAGING | 186 |
| B80-2 ABNORMALITIES IN STRUCTUREAND FUNCTION IN COPD | 187 |
| B80-3 OSA 2.0: LEVELING UP THE SLEEPAPNEA TOOL KIT | 188 |
| B80-4 THE Z-FILES OF SLEEP PUZZLES | 189 |
| B80-5 DIAGNOSING LUNG CANCER: MORETHAN A SCAN | 190 |
| B80-6 GET ME TO THE AIRWAYS: IP,CENTRAL TUMORS, AND MORE | 190 |
| B80-7 DIAGNOSTIC DILEMMAS INTHORACIC ONCOLOGY | 191 |
| B80-8 UNCOMMON COMPLICATIONS INTHORACIC ONCOLOGY | 192 |
| ME102 WINNING WITH WORDS: PUBLICSPEAKING SKILLS FOR CLINICIANS,EDUCATORS & SCIENTISTS | 193 |
| MONDAY MID-DAY | 194 |
| ATS WOMEN’S FORUM | 194 |
| SPS5 PREVENTING RSV: PROVIDINGOLDER PATIENTS WITH THEINFORMATION THEY NEED | 194 |
| CC3 ADULT PULMONARY CLINICAL CORECURRICULUM | 194 |
| MD14 FROM THE ATS SCHOLAR EDITORS:PEARLS AND PITFALLS IN HEALTHPROFESSIONS EDUCATIONRESEARCH | 195 |
| MD15 RED IN ACTION II: LUNG RESEARCHHIGHLIGHTS FROM AJRCMB | 195 |
| MD16 RESEARCH FUNDING OPPORTUNITIES | 196 |
| MD17 ASTHMA ACROSS SPECIES: ACOMPARATIVE APPROACH TOUNDERSTANDING PATHOLOGY ANDTHE MICROBIOTA | 196 |
| MD18 NEW OMICS FINDINGS FROM THENHLBI PVDOMICS PROGRAM INPULMONARY HYPERTENSIONPATIENTS | 197 |
| MD19 OVERVIEW OF CDC’S SUPPORT,COLLABORATION, AND RESPONSE WORKRELATED TO WILDLAND FIRES | 197 |
| MD20 AN UPDATE FROM THE PRECISIONINTERVENTIONS FOR SEVEREAND/OR EXACERBATION-PRONEASTHMA (PRECISE) NETWORK | 198 |
| MD21 CONNECTING NASA EARTH SCIENCEAPPLICATIONS WITH AIR QUALITYAND RESPIRATORY HEALTH | 198 |
| MD22 ARDS, PNEUMONIA, AND SEPSISPHENOTYPING CONSORTIUM | 199 |
| MD23 TUBERUCLOSIS (TB) RESEARCHAND PROVIDER/COMMUNITYENGAGEMENT UPDATES FROM CDC | 199 |
| MD24 NEW FINDINGS FROM THESUBPOPULATIONS AND INTERMEDIATEOUTCOMES IN COPD STUDY (SPIROMICS )FAMILY OF STUDIES: SPIROMICS, SOURCE,SPIROMICS HF | 200 |
| MD25 UPDATES ON LUNG HALLMARKS OFAGING | 200 |
| MD26 RESEARCH IN VHA’S LPOP PROVIDESIMPORTANT OPPORTUNITIES TOIMPROVE LUNG CANCER SCREENING | 201 |
| MD27 TRANS-OMICS FOR PRECISIONMEDICINE (TOPMED) PHASE 2: FROMWGS TO FUNCTIONAL GENOMICS | 201 |
| PCC2 PEDIATRIC CLINICAL CORECURRICULUM 2 | 202 |
| MONDAY AFTERNOON | 202 |
| CC4 ADULT SLEEP CLINICAL CORECURRICULUM | 202 |
| SPS6 POPULATION DIVERSITY INCLINICAL TRIALS | 203 |
| B81 NURSING YEAR IN REVIEW:IMPLEMENTATION IN PULMONARY,CRITICAL CARE AND SLEEP | 203 |
| B82 SCREENING AND EARLY DIAGNOSISOF ILD IN PATIENTS WITHCONNECTIVE TISSUE DISEASE | 203 |
| B83 ARTIFICIAL INTELLIGENCE IN THERADIOLOGICAL ASSESSMENT OFINTERSTITIAL LUNG DISEASE | 204 |
| B84 INTEGRATING GERIATRICPRINCIPLES AND PRACTICES INTOCRITICAL CARE AND ICU RECOVERY | 205 |
| B85 LUNG HARMONY: UNRAVELLING THESYNERGY BETWEEN MACROPHAGESAND ALVEOLAR EPITHELIAL CELLSIN DISEASE | 205 |
| B86 AN INCONVENIENT TRUTH: HEALTHDISPARITIES AND HEALTH CAREINEQUALITY IN RESPIRATORYMEDICINE | 206 |
| B87 IMMUNE MECHANISMS OF ACUTELUNG INJURY FROM COVID ANDBEYOND | 207 |
| B88 CUTTING EDGE VACCINE DEVELOPMENTFOR THE PULMONARY SUB-SPECIALTYCOMMUNITY: VACCINE IMMUNOLOGY,RESEARCH, DEVELOPMENT, ANDPRACTICE SOLUTIONS | 207 |
| B89 INTERNATIONAL PERSPECTIVE ONTOBACCO/VAPINGPRODUCT/HEATED TOBACCOPRODUCT DEPENDENCE ANDCONTROL | 208 |
| B90 IMPACT OF THE GUT-LUNG AXIS ONRESPIRATORY HEALTH ACROSS THELIFESPAN | 208 |
| B91 WHERE ARE THEY NOW?FUNCTIONAL LUNG IMAGINGNEARING CLINICAL APPLICATION | 209 |
| B93 EARLY DISEASE TRAJECTORIES:PRISM, PRE-COPD, EARLY COPD ANDBEYOND | 209 |
| B94 BEST OF PEDIATRICS | 210 |
| B95 SURFING IN THE GREEN ROOM:DEFINING MOLECULAR MECHANISMSOF PULMONARY VASCULAR DISEASE | 210 |
| B96 WHAT IS NEW IN PNEUMONIA? | 211 |
| B97 ADVANCED INSIGHTS INTOPULMONARY REHABILITATION | 211 |
| B98 HEALING LUNGS: NAVIGATING THEPATHWAYS OF LUNG REPAIR | 212 |
| B99 SLEEP APNEA UNPLUGGED:NAVIGATING A MYRIAD OF HEALTHOUTCOMES | 212 |
| B101 COPD EPIDEMIOLOGY, DISPARITIES,AND HEALTH SERVICES RESEARCH | 213 |
| B102 OPTIMIZING ICU PROCESSES ANDCARE: ADOPTING BEST PRACTICES | 214 |
| B103 PERSONALIZING CARE FORPATIENTS WITH ACUTERESPIRATORY FAILURE | 215 |
| B104 CASE REPORTS IN INTERVENTIONALPULMONARY AND PLEURALDISEASE | 216 |
| B105 BREATHING AMIDST ADVERSITY:EXPLORING THE IMPACT OF AIRPOLLUTION ON RESPIRATORYHEALTH AND BEYOND | 217 |
| B106 TUBERCULOSIS BREAKTHROUGHS | 218 |
| B107 GENETIC AND TRANSCRIPTOMICSIGNATURES IN LUNG DISEASES | 219 |
| B108 BREATHE EASY: NAVIGATING THEWORLD OF VENTILATORYDISORDERS | 220 |
| B109 DIVING INTO DISCOVERY: CURRENTSOF BASIC SCIENCE ANDIMMUNOTHERAPIES IN LUNGCANCER | 220 |
| B110 ADVANCES IN PRECISIONAPPROACHES TO DETECTION ANDTREATMENT OF EARLY LUNGCANCER | 221 |
| TUESDAY, MAY 21 | 223 |
| TUESDAY MORNING | 223 |
| MEET THE EXPERT SEMINARS | 223 |
| K3: KEYNOTE SERIES | 223 |
| C1 CLINICAL YEAR IN REVIEW 1 | 223 |
| C2 DECENTRALIZED CLINICAL TRIALS:EASIER FOR PATIENTS ANDPULMONOLOGISTS | 224 |
| C3 PEDIATRIC CLINICAL CHEST ROUNDS | 224 |
| C4 CARE OF THE DYING IN THE ICU: ENDOF LIFE CARE IN 2024 AND BEYOND | 225 |
| C5 WHAT’S FAT GOT TO DO WITH IT?NEW EVIDENCE FOR THE INFLUENCEOF OBESITY ON CHRONIC AIRWAYSDISEASE | 225 |
| C6 ENVIRONMENTAL INFLUENCE ONLUNG HEALTH | 226 |
| C7 ELEVATING THE QUALITY OF DELIVERYOF SUPPLEMENTAL OXYGEN | 226 |
| C8 MOVING THE NEEDLE IN THE RIGHTDIRECTION: A PRO-CON DEBATE ONSTRATEGIES FOR LUNG NODULEBIOPSIES | 227 |
| C9 RHINOVIRUS INFECTION OF THEAIRWAY EPITHELIUM IN ASTHMA | 228 |
| C10 BEYOND TOBACCO: Non-SMOKINGCAUSES OF COPD | 228 |
| C11 COHORT STUDIES IN PULMONARYHYPERTENSION - DEFINING NOVELPHENOTYPES | 229 |
| C12 CARING FOR THE HEALERS | 229 |
| C13 REASSESSING THE VALUE OFPHYSIOLOGIC ENDOTYPES INUNDERSTANDING OSAHETEROGENEITY | 230 |
| C14 HARMONY IN HEALING: IMMUNECELL CHOREGRAPHY OF LUNGINJURY AND REPAIR | 230 |
| C15 COPD EPIDEMIOLOGY, TREATMENT,AND DISPARITIES | 231 |
| C16 SEPSIS IN 2024: FROM BENCH TOBEDSIDE AND AROUND THE WORLD | 231 |
| C17 PEDIATRIC IMPACT OF COVID-19 ANDOTHER RESPIRATORY INFECTIONS | 232 |
| C18 TRANSLATING SCIENCE INRESPIRATORY INFECTIONS | 232 |
| C19 CHARTING THE LUNG: INNOVATIONIN MULTIOMICS | 233 |
| C20 HAVING A GROWTH MINDSET:REPROGRAMMING CELLULARPATHWAYS TO DISEASE | 233 |
| C21 MIND, BODY AND AGING AFTER THEICU: A CC/BSHSR COLLABORATIVESESSION | 234 |
| C22 ARTIFICIAL INTELLIGENCE IN THEICU: THE MACHINE WILL SEE YOUNOW | 235 |
| C23 MACHINE LEARNED: AI-DRIVENSOLUTIONS IN ILD AND LUNGTRANSPLANT | 236 |
| C24 CLINICAL, BIOLOGIC, ANDRADIOLOGIC MARKERS OF KEYOUTCOMES AND TREATMENTRESPONSE IN COPD | 237 |
| C25 GASLAMP QUARTER: SHEDDINGLIGHT ON VASCULAR PATHOGENICMECHANISMS IN PAH | 238 |
| C26 NOVEL TECHNOLOGIES ANDIMAGING APPROACHES IN PEDIATRICRESPIRATORY MEDICINE | 239 |
| C27 NTM/BRONCHIECTASIS RAPID FIREPOSTERS | 239 |
| C28 MORE THAN MEET THE EYE: NOVELINSIGHTS IN IPF PATHOGENESIS | 240 |
| C29 ADVANCED LUNG IMAGING; THEPULMONARY PAPARAZZI | 241 |
| C30 APNEA AWAKENING: DECODINGINTERMITTENT HYPOXIA | 242 |
| C31 WHAT’S NEW IN CLINICAL ASTHMA | 242 |
| C32 ALL THAT WHEEZES (AND THENSOME): CASE STUDIES | 244 |
| C33 ATTACK OF THE ANTIBODIES: CASESTUDIES | 245 |
| C34 BIOLOGIC THERAPY IN THE FIGHTAGAINST ASTHMA AND ALLERGICINFLAMMATION | 246 |
| C35 INNOVATIVE BIOMARKERS TOIDENTIFY ALLERGIC INFLAMMATION | 248 |
| C36 ADVANCES IN COVID-19, LUNGINFECTION, AND TUBERCULOSIS | 249 |
| C37 HEALTH SERVICES RESEARCH INPULMONARY HYPERTENSION | 249 |
| C38 ADVANCES IN MEDICAL EDUCATIONIN PULMONARY, CRITICAL CARE,AND SLEEP MEDICINE | 250 |
| C39 PNEUMONIA AND SEPSIS:EPIDEMIOLOGY, TREATMENTS, ANDOUTCOMES | 251 |
| C40 ARDS AND ACUTE RESPIRATORYFAILURE: MECHANISM, RISK, ANDOUTCOMES | 252 |
| C41 PUMP YOU UP - ECMO AND CARDIACDEVICE OPTIMIZATION | 253 |
| C42 ALL ABOUT THE AIRWAYS ANDALVEOLI: RESPIRATORY FAILURECASE REPORTS | 254 |
| C43 BRAIN-STORMS: NEUROLOGICCRITICAL CARE CASES | 256 |
| C44 TOXIDROMES AND ADVERSEMEDICATION REACTIONS IN THE ICU | 257 |
| C45 CARDIAC CRITICAL CARE: AT THEHEART OF THE MATTER | 259 |
| C46 CLINICAL AND PHYSIOLOGICMETRICS OF RESPIRATORY DISEASEAND COPD: FROM DIAGNOSIS TOPROGNOSIS | 260 |
| C47 COMPLICATIONS, CONSTRICTIONS,BLOOD AND FOREIGN BODIES:AIRWAY CASE REPORTS ININTERVENTIONAL PULMONARY | 261 |
| C48 CASE REPORTS IN VASCULITIS LUNGDISEASE | 262 |
| C49 PROCEDURAL COMPLICATIONS ANDCOMPLEX CLINICAL MANAGEMENT ININTERVENTIONAL PULMONARY ANDPLEURAL DISEASE | 262 |
| C50 CASE REPORTS IN COPD ANDALPHA-1-ANTITRYPSIN DEFICIENCY | 263 |
| C51 CASE REPORTS IN COUGH, CYSTICFIBROSIS, AND BRONCHIECTASIS | 264 |
| C52 CASE REPORTS IN RARE LUNGDISEASE | 265 |
| C53 CASE REPORTS IN SARCOIDOSIS | 266 |
| C54 CASE REPORTS IN LUNGTRANSPLANT | 267 |
| C55 COMORBIDITIES OF COPD:EPIDEMIOLOGY AND TREATMENTIMPLICATIONS | 268 |
| C56 NAVIGATING OCCUPATIONALHAZARDS: CASE REPORTS INWORK-RELATED LUNG DISEASE | 268 |
| C57 MEDICAL MYSTERIES UNVEILED:CASE REPORTS HIGHLIGHTING RARERESPIRATORY CONDITIONS | 269 |
| C58 BACK TO WHERE IT ALL BEGAN:EMERGING CLINICAL INSIGHTS INTOCTEPH | 270 |
| C59 PICKING UP THE KIDS AT BALBOAPARK: INSIGHTS IN PEDIATRICPULMONARY HYPERTENSION | 270 |
| C60 BEACHCOMBING FOR GOLD: -OMICS,INFLAMMATION, AND THE RV IN PH | 271 |
| C61 FINDING HIDDEN GEMS AT SUNSETCLIFFS: NOT JUST PE AND PH!PULMONARY VEINS, AVMS, ANDOTHER PULMONARY VASCULARCASES | 271 |
| C62 TOP GUN: NOVEL THERAPEUTICSAND OUTCOMES IN PAH | 273 |
| C63 PEDIATRIC IMMUNOLOGY,ONCOLOGY, PHYSIOLOGY, AND CELLBIOLOGY | 274 |
| C64 PEDIATRIC ASTHMA | 275 |
| C65 PEDIATRIC RESPIRATORY FAILURE,CRITICAL CARE, AND VASCULARPULMONARY DISEASE | 276 |
| C66 BEHAVIORAL, ENVIRONMENTAL, ANDHEALTH SERVICES RESEARCH INPEDIATRIC PULMONOLOGY | 277 |
| C67 SCIENCE AND BEDSIDE BACTERIALPNEUMONIA | 278 |
| C68 NTM: CHALLENGING SCIENCE ANDCASES | 280 |
| C69 FUNGAL INFECTION CHALLENGES | 281 |
| C70 FROM BUDS TO BREATH:MECHANISMS AND PATHOGENESISOF LUNG DEVELOPMENT | 282 |
| C71 ASTHMA CLINICAL PHENOTYPES ANDTHERAPIES | 283 |
| C72 CASE REPORTS IN RESPIRATORYSTRUCTURE AND FUNCTION | 284 |
| C73 PRECLINICAL MODELING OFPULMONARY INFLAMMATION ANDEMPHYSEMA | 285 |
| C74 CYSTIC FIBROSIS AND NON-CFBRONCHIECTASIS | 287 |
| C75 STRUCTURAL AND FUNCTIONALCONSEQUENCES OF COVID | 287 |
| C76 SLEEP DISORDERS IN UNCOMMONREALMS | 288 |
| C77 NEEDLES AND KNIVES:INVESTIGATING LUNG CANCERDIAGNOSIS AND TREATMENT | 288 |
| C78 WHAT’S THAT? ATYPICAL AND RAREPRESENTATIONS IN THORACICONCOLOGY | 289 |
| C79 INFECTIONS AND CRITICAL ILLNESS:CHALLENGES IN THORACICONCOLOGY | 291 |
| C80 THORACIC COMPLICATIONS OFCANCER DRUGS ANDIMMUNOTHERAPIES | 291 |
| ME103 INFLUENCE, INSPIRE, INNOVATE:DEVELOPING LEADERSHIP SKILLSACROSS HEALTHCARE DISCIPLINES | 292 |
| SPS7 THE UNTOLD STORY OF THENURSES WHO HELPED CURETUBERCULOSIS | 292 |
| TUESDAY AFTERNOON | 293 |
| PLENARY SESSION | 293 |
| CC5 ADULT CRITICAL CARE CLINICALCORE CURRICULUM | 293 |
| C81 CURRENT AND EVOLVINGSTRATEGIES FOR MANAGEMENT OFPULMONARY SARCOIDOSIS | 294 |
| C82 PRO CON DEBATE ON PROGRESSIVEPULMONARY FIBROSIS: IMPROVINGUNDERSTANDING OF A DISEASEPHENOTYPE | 294 |
| C83 WHEN SEPSIS GOES VIRAL:RECONSIDERING SEPSIS IN THEPOST-COVID ERA | 295 |
| C84 NOVEL AND NEGLECTEDENVIRONMENTAL EXPOSURES ANDLUNG HEALTH | 296 |
| C85 ATS DOCUMENTS: ADVANCING ANDIMPROVING CLINICAL PRACTICE | 296 |
| C86 PULMONARY REHABILITATION -KEEPING THE WHEEL ROLLINGFORWARD | 297 |
| C87 MACHINE LEARNING IN PEDIATRICPULMONOLOGY | 297 |
| C88 HEALTH EQUITY ACROSS PEDIATRICPULMONARY DISEASES | 298 |
| C89 HIV-RELATED LUNG DISEASE:UPDATES IN PATHOPHYSIOLOGY,CLINICAL TRIALS AND FUTUREDIRECTIONS | 298 |
| C90 STATE OF THE SCIENCE ON ICUDELIRIUM | 299 |
| C92 SUBSTANCE USE DISORDERS INPULMONARY, CRITICAL CARE, ANDSLEEP MEDICINE | 299 |
| C93 ADVANCES IN HEALTH SERVICESRESEARCH IN SLEEP MEDICINE | 300 |
| C94 ASTHMA QUALITY IMPROVEMENT,HEALTH SERVICES RESEARCH, ANDDISPARITIES | 301 |
| C95 NEW CLINICAL TRIAL RESULTS INCHRONIC LUNG DISEASE | 301 |
| C96 PRECISION MEDICINE IN CRITICALCARE: EXPLORING ARDS ANDSEPSIS PHENOTYPES | 302 |
| C97 TOBACCO, E-CIGARETTES, AND AIRPOLLUTION: MAJOR ENVIRONMENTALTHREATS TO LUNG HEALTH | 302 |
| C98 ENERGIZING THE LUNG:MITOCHONDRIA AND METABOLICPATHWAYS | 303 |
| C99 I CAN SEE THE FUTURE: NOVELWAYS TO PREDICT COPD | 303 |
| C100 NEW FRONTIERS IN LUNG CANCER:TOYS, TOOLS AND TREATMENTS | 304 |
| C101 UNDERSTANDING LUNG IMMUNITY INTHE BATTLE AGAINST INFECTION | 304 |
| C102 CLINICAL AND TRANSLATIONALADVANCES IN ASTHMA | 305 |
| C103 DISPARITIES AND SOCIALDETERMINANTS OF HEALTH INPULMONARY, CRITICAL CARE, ANDSLEEP MEDICINE | 306 |
| C104 BLEEDING AND CLOTTING ANDEMBOLI, OH MY! HEMATOLOGICCASES IN THE ICU | 307 |
| C105 RESPIRATORY REVELATIONS:EPIDEMIOLOGIC STUDIES INASTHMA, COPD, AND LUNGFUNCTION | 308 |
| C106 CORONADO BRIDGE: LINKINGNOVEL EXTRA-THORACIC DISEASEMECHANISMS WITH PAH | 309 |
| C107 MICROBIAL RESPIRATORYINFECTIONS DISCOVERIES | 310 |
| C108 MECHANISMS OF LUNGINFLAMMATION AND INFECTION | 311 |
| C109 PAP THERAPY CHRONICLES: THEART OF RESTFUL NIGHTS | 312 |
| C110 SURFING THE INNOVATION WAVE INSAN DIEGO: CUTTING-EDGE LUNGCANCER BIOMARKERS, DIAGNOSTICSAND TREATMENTS | 312 |
| WEDNESDAY, MAY 22 | 314 |
| WEDNESDAY MORNING | 314 |
| MEET THE EXPERT SEMINARS | 314 |
| D1 CLINICAL YEAR IN REVIEW 1 | 314 |
| D2 A NEW REALITY FOR CRITICAL CAREAFTER DOBBS | 315 |
| D3 INTERSTITIAL LUNG ABNORMALITIES:MOVING THE NEEDLE TOWARDSTHERAPEUTIC CLINICAL TRIALS | 315 |
| D4 LYMPHANGIOLEIOMYOMATOSIS: ATTHE FOREFRONT OF SCIENTIFIC ANDCLINICAL PROGRESS | 316 |
| D5 TIME-LIMITED TRIALS IN CRITICALCARE | 316 |
| D7 WHERE CHILDREN LEARN ANDBREATHE: THE IMPACT OFSCHOOL-BASED EXPOSURES ONCHILDHOOD RESPIRATORY HEALTH | 317 |
| D8 GLOBAL PERSPECTIVES OFPULMONARY HYPERTENSIONBIOLOGY AND MANAGEMENT? ANATS/ERS JOINT SYMPOSIUM | 318 |
| D9 LINKING NOVEL MULTI-OMICS WITHMACHINE LEARNING TO UNLOCKLUNG PATHOPHYSIOLOGY | 319 |
| D10 TEAMWORK MAKES THE DREAMWORK: MULTIDISCIPLINARYAPPROACHES FOR HIGH-QUALITYLUNG CANCER SCREENING | 319 |
| D12 POUR SOME SUGAR ON ME:METABOLISM IN LUNG INJURY ANDREPAIR | 320 |
| D13 DETERMINANTS OF DISEASEPROGRESSION AND DECLINE INCOPD | 321 |
| D14 ACUTE RESPIRATORY FAILURE ANDMECHANICAL VENTILATION:EXPANDING OUR BREADTH OFKNOWLEDGE | 321 |
| D15 MACHINE LEARNING AND LARGECOHORT STUDIES TO UNDERSTANDEXPOSURE-RELATED LUNG DISEASE | 322 |
| D16 GENETICS AND BRONCHIECTASIS -ADVANCES IN CYSTIC FIBROSIS ANDPRIMARY CILIARY DYSKINESIA | 322 |
| D17 WHAT’S HOT IN TUBERCULOSIS? | 323 |
| D19 UNRAVELING THE IMPACT OF OSAON NEUROCOGNITIVE FUNCTION | 324 |
| D20 NOVEL INSIGHTS IN LUNG CANCER:MECHANISTIC ORIGINS TOOUTCOMES | 324 |
| D21 TERMINATOR: CONTROL OF AIRWAYINFLAMMATION AND IMMUNERESPONSE IN ASTHMA | 325 |
| D22 ADVANCES IN HEALTH SERVICESRESEARCH IN ASTHMA | 326 |
| D23 DON’T LOSE YOUR HEAD! CRITICALCARE CASES WITH NEUROLOGICCONSEQUENCES | 327 |
| D24 IF IT QUACKS LIKE A ZEBRA:INTERESTING CASE REPORTS INDIFFUSE PARENCHYMAL LUNGDISEASE | 327 |
| D25 EMERGING RESEARCH IN COUGH,CYSTIC FIBROSIS ANDBRONCHIECTASIS | 328 |
| D26 UNVEILING CONNECTIONS:TOBACCO, CANNABIS,E-CIGARETTES, AND RESPIRATORYHEALTH INSIGHTS | 329 |
| D27 LATE BREAKING WAVE! LATEBREAKING ABSTRACTS INPULMONARY VASCULAR DISEASE | 330 |
| D28 PEDIATRIC PULMONOLOGYBENCH-TO-BEDSIDE: GENETICS,WHOLE-EXOME SEQUENCING, ANDOMICS | 331 |
| D29 INSIGHTS INTO MECHANISMS ANDEFFECTIVENESS OF DIFFERENTCOMPONENTS OF PULMONARYREHABILITATION | 332 |
| D30 A NARROW ROAD TO AIRWAYHYPERRESPONSIVENESS | 332 |
| PCC3 PEDIATRIC CLINICAL CORECURRICULUM 3 | 333 |
| WEDNESDAY MID-DAY | 334 |
| CC6 ADULT CRITICAL CARE CLINICALCORE CURRICULUM | 334 |
| MD28 NAVIGATING A SUCCESSFULCAREER: POSITIONING YOURSELFFOR A NATIONAL PRESENCE | 335 |
| MD29 THE PEDIATRICADENOTONSILLECTOMY TRIAL FORSNORING (PATS): KEY OUTCOMESAND IMPLICATIONS | 335 |
| MD30 CLINICAL TRIAL STRATEGIES FORRARE LUNG DISEASE ANDDIFFICULT TO REACH POPULATIONS | 336 |
| MD31 GENERIC DRUG DEVELOPMENT FORRESPIRATORY PRODUCTS, US FOODAND DRUG ADMINISTRATIONUPDATE | 336 |
| MD32 POSTOPERATIVE PULMONARYCOMPLICATIONS: FROM PHYSIOLOGYAND BIOLOGY TO A PREVENTIVEPERIOPERATIVE CLINICAL TRIAL | 337 |
| WEDNESDAY AFTERNOON | 338 |
| D81 MONEY AND THE ICU: FINANCIALMOTIVATORS AND CONSEQUENCESOF CRITICAL CARE | 338 |
| D82 WHO WHAT WHERE WHY HOW?INHALATIONAL EXPOSURES AND ILD | 338 |
| D83 RESPIRATORY HEALTH IMPACTS OFHUMAN MADE DISASTERS ANDNATURAL DISEASTERS, WILDFIRES,EARTHQUAKES, AND VOLCANOES. | 339 |
| D84 EMERGENT RESISTANCE TO NEWDRUGS FOR MDR-TB TREATMENT | 340 |
| D85 ONE TO RULE THEM ALL? IMMUNECELLS CONTROL STEM CELLCAPACITY IN THE LUNG | 340 |
| D86 AMBULATORY CRITICAL CARE: ABENCH TO BEDSIDE UNDERSTANDINGOF CHRONIC RESPIRATORY FAILURE | 341 |
| D91 BRIDGING THE GAP: TRANSLATIONALSTUDIES IN ARDS, PNEUMONIA, ANDSEPSIS | 341 |
| D92 BOOKENDS: ILAS TO PPF | 342 |
| D93 LOOKING BEYOND THE LUNGS:COPD AND COMORBIDITIES | 342 |
| D94 EQUITY IN CRITICAL CARE:UNVEILING DISPARITIES IN ACCESS,OUTCOMES, AND RESEARCHINCLUSION | 343 |
| D95 SURVEYING THE ZOO: -OMICS FORMECHANISTIC DISCOVERY INPULMONARY VASCULAR DISEASE | 343 |
| D96 BREATH BEYOND: NOVEL INSIGHTSIN LUNG INJURY | 344 |
| D97 FEELING STUCK? MECHANISMS OFMUCOCILIARY (DYS)FUNCTION | 344 |
| D101 UNCOVERING THE METABOLIC ANDGENETIC UNSOLVED MYSTERIES INASTHMA | 344 |
| D102 HOT TOPICS IN BEHAVIORALSCIENCE AND HEALTH SERVICESRESEARCH | 345 |
| D103 BE PREPARED! RAREPRESENTATIONS AND TREATMENTSIN THE ICU | 346 |
| D104 CASE REPORTS IN DYSPNEA ANDCOMPLEX LUNG DISEASES | 347 |
| D105 BALBOA PARK EXPLORERS:TRANSLATIONAL SCIENCE ANDEPIDEMIOLOGY IN PH | 348 |
| D106 CUTTING-EDGE SCIENCE ONBRONCHOPULMONARY DYSPLASIA | 349 |
| D107 THE BEST OF RESPIRATORYINFECTIONS CASE REPORTS | 350 |
| D108 SIGNALING PATHWAYS IN AIRWAYREGENERATION AND REPAIR | 351 |
| D109 NOW WE GOT BAD BLOOD: RSF/PCJOINT SESSION ON PULMONARYVASCULAR DISEASE | 352 |
| D110 PUZZLING PRESENTATIONS ANDCOMPLEX DIAGNOSES: NAVIGATINGTHE DIVERSE LANDSCAPE OFTHORACIC ONCOLOGY | 353 |
| BACK COVER | 4 |